PlainRecalls
FDA Drug Moderate Class II Terminated

Fluphenazine Decanoate Injection USP 125mg/5mL, (5 mL Multiple Dose Vial), Rx only, For IM or SC Use, Mfd in India for: AuroMedics Pharma, LLC, E. Windsor, NJ

Reported: December 11, 2019 Initiated: November 12, 2019 #D-0609-2020

Product Description

Fluphenazine Decanoate Injection USP 125mg/5mL, (5 mL Multiple Dose Vial), Rx only, For IM or SC Use, Mfd in India for: AuroMedics Pharma, LLC, E. Windsor, NJ

Reason for Recall

Discoloration; Hazy solution found in one vial instead of a clear solution.

Details

Recalling Firm
AuroMedics Pharma LLC
Units Affected
59,500 vials
Distribution
Product was distributed to major wholesalers/distributors who may have further distribute the product throughout the United States.
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Fluphenazine Decanoate Injection USP 125mg/5mL, (5 mL Multiple Dose Vial), Rx only, For IM or SC Use, Mfd in India for: AuroMedics Pharma, LLC, E. Windsor, NJ. Recalled by AuroMedics Pharma LLC. Units affected: 59,500 vials.
Why was this product recalled?
Discoloration; Hazy solution found in one vial instead of a clear solution.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 11, 2019. Severity: Moderate. Recall number: D-0609-2020.